Malignant Tumors Clinical Trials

6 recruiting

Malignant Tumors Trials at a Glance

31 actively recruiting trials for malignant tumors are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 1 with 21 trials, with the heaviest enrollment activity in Shanghai, Wuhan, and Guangzhou. Lead sponsors running malignant tumors studies include Shenyang Sunshine Pharmaceutical Co., LTD., LaNova Medicines Limited, and Akeso.

Browse malignant tumors trials by phase

Treatments under study

About Malignant Tumors Clinical Trials

Looking for clinical trials for Malignant Tumors? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Malignant Tumors trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Malignant Tumors clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Not Applicable

Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies

Liver Malignant Tumors
Seoul National University Hospital128 enrolled1 locationNCT06426992
Recruiting
Phase 1

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

NeoplasmCancer, Malignant Tumors
Compugen Ltd200 enrolled11 locationsNCT06759649
Recruiting
Not Applicable

Histotripsy for Ablation of Liver Tumours in Asia

Liver Malignant Tumors
National Cancer Centre, Singapore40 enrolled3 locationsNCT07428356
Recruiting
Phase 1

A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.96 enrolled1 locationNCT07038005
Recruiting
Phase 1Phase 2

Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital20 enrolled1 locationNCT07399769
Recruiting
Phase 1Phase 2

Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection

Biliary Malignant Tumors
Yifan Wang20 enrolled1 locationNCT07368803
Recruiting
Phase 1Phase 2

First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors

Advanced Malignant Tumors
Shanghai JMT-Bio Inc.436 enrolled1 locationNCT06877650
Recruiting
Phase 1

A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.15 enrolled1 locationNCT07016490
Recruiting
Phase 1Phase 2

A Study of LM-350 in Subjects With Advanced Solid Tumours

Malignant Tumors
LaNova Medicines Limited80 enrolled4 locationsNCT07112222
Recruiting
Phase 1Phase 2

Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors

Patients With Advanced or Metastatic Malignant Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.203 enrolled1 locationNCT07073534
Recruiting
Phase 1

A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.216 enrolled19 locationsNCT07043751
Recruiting

Clinical Application of FL-091 Radionuclide Imaging in Diagnosis and Staging of Malignant Tumors

Malignant Tumors With Positive NTSR1 Expression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology100 enrolled1 locationNCT06977945
Recruiting
Early Phase 1

Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors

PETSSTR2Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology10 enrolled1 locationNCT07301801
Recruiting
Not Applicable

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Pancreatic CancerMelanomaLiver Malignant Tumors+1 more
M.D. Anderson Cancer Center60 enrolled1 locationNCT05053555
Recruiting
Not Applicable

High-Resolution PET-CT Imaging for Surgical Margin Visualization

CancerHNSCCSCC - Squamous Cell Carcinoma+2 more
Vanderbilt-Ingram Cancer Center50 enrolled1 locationNCT06915454
Recruiting

Molecular Basis of Pediatric Liver Cancer

Hepatocellular CarcinomaLiver Malignant TumorsHepatoblastoma+3 more
University of Pittsburgh1,600 enrolled1 locationNCT03959800
Recruiting
Phase 1

A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors

Malignant Tumors of Adults
Suzhou Suncadia Biopharmaceuticals Co., Ltd.102 enrolled2 locationsNCT07068932
Recruiting
Phase 1

A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.30 enrolled1 locationNCT07032298
Recruiting
Phase 1

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Malignant Tumors
Sichuan University20 enrolled1 locationNCT07004244
Recruiting
Phase 1Phase 2

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd468 enrolled6 locationsNCT05779163